COMPANIES COVERED
CepheidDownload FREE Report Sample
Download Free sampleNext Generation Cancer Diagnostics Market contains market size and forecasts of Next Generation Cancer Diagnostics in Global, including the following market information:
Global Next Generation Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Next Generation Cancer Diagnostics market was valued at 6377.6 million in 2021 and is projected to reach US$ 19960 million by 2028, at a CAGR of 17.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Next Generation Sequencing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Next Generation Cancer Diagnostics include Cepheid, Koninklijke Philips N.V, F. Hoffmann-La Roche Ltd, Qiagen, Novartis AG, Abbott, Thermo Fisher Scientific, Opko Health and Myriad Genetics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Next Generation Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Next Generation Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Global Next Generation Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Next Generation Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Next Generation Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Next Generation Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Next Generation Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
